Covered recipient · General Payments record
HANS D REISINGER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$1,344.83
- Reported across 75 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $614.67 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $217.49 | 11 |
| PFIZER INC. | $112.91 | 6 |
| Novo Nordisk AS | $56.08 | 3 |
| Lilly USA, LLC | $47.98 | 3 |
| Phathom Pharmaceuticals, Inc. | $44.84 | 3 |
| Exact Sciences Corporation | $38.75 | 2 |
| Abbott Laboratories | $31.37 | 2 |
| DEXCOM, INC. | $18.76 | 1 |
| Merck Sharp & Dohme Corporation | $17.53 | 1 |
| E.R. Squibb & Sons, L.L.C. | $15.55 | 1 |
| Acerta Pharma LLC | $13.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.86 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125194694 | CMS |
| Abbott Laboratories | $17.51 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125194698 | CMS |
| ABBVIE INC. | $33.93 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108074042 | CMS |
| ABBVIE INC. | $6.32 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108074044 | CMS |
| ABBVIE INC. | $9.70 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108074046 | CMS |
| ABBVIE INC. | $34.56 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108074048 | CMS |
| ABBVIE INC. | $6.53 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108074050 | CMS |
| ABBVIE INC. | $15.46 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108074052 | CMS |
| ABBVIE INC. | $18.52 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108074054 | CMS |
| ABBVIE INC. | $32.93 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108074056 | CMS |
| ABBVIE INC. | $21.53 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108074058 | CMS |
| ABBVIE INC. | $19.40 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108074060 | CMS |
| ABBVIE INC. | $18.61 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108074062 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.41 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104577200 | CMS |
| Dexcom, Inc. | $18.76 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153362460 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.55 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101652291 | CMS |
| Exact Sciences Corporation | $19.06 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114441817 | CMS |
| Exact Sciences Corporation | $19.69 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114441822 | CMS |
| Lilly USA, LLC | $18.53 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135640326 | CMS |
| Lilly USA, LLC | $16.04 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135675798 | CMS |
| Lilly USA, LLC | $13.41 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135687536 | CMS |
| Merck Sharp & Dohme LLC | $17.53 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141985827 | CMS |
| Novo Nordisk Inc | $17.85 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100518283 | CMS |
| Novo Nordisk Inc | $21.91 | 05/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100513149 | CMS |
| Novo Nordisk Inc | $16.32 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100592254 | CMS |
| PFIZER INC. | $14.12 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131125098 | CMS |
| PFIZER INC. | $21.80 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131039368 | CMS |
| PFIZER INC. | $16.48 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131475138 | CMS |
| PFIZER INC. | $19.32 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131611320 | CMS |
| PFIZER INC. | $16.69 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131956659 | CMS |
| PFIZER INC. | $24.50 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131206429 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.99 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151199877 | CMS |
| Phathom Pharmaceuticals, Inc. | $14.99 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151199879 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.86 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151199881 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.